The heart medicine, Valsartan, was recently pulled from U.S. pharmacies, as well as those in other countries like Germany, Canada, France, and Sweden.
The Chinese supplier, ZHP, issued a recall notice in July after finding traces of a dangerous carcinogen in substances supplied for the production of Valsartan. China’s Food and Drug Administration said that it screened all Chinese suppliers of the Valsartan ingredients to mitigate further problems.
This incident follows other recent recalls of Chinese-made vaccines for diphtheria and tetanus (DPT) and rabies.
- Valsartan: FDA recalls common heart drug, joins 22 other countries
- FDA recalls blood pressure, heart failure medications due to potential cancer risk
Check out related OM in the News posts about the risk to national security when the supply chain becomes too lean, and several medical supply shortages.
This post is based on the CNN article, Chinese company recalls tainted heart medicine from stores worldwide, by Ben Wescott and Yong Xiong, July 30, 2018; and the YouTube videos, Valsartan: FDA recalls common heart drug, joins 22 other countries, by ABC Action News, July 16, 2018, and FDA recalls blood pressure, heart failure medications due to potential cancer Continue reading